Stay updated with breaking news from Path Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Parallel Advisors LLC reduced its stake in UiPath Inc. (NYSE:PATH – Free Report) by 80.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,952 shares of the healthcare company’s stock after selling 16,130 shares during the period. Parallel Advisors LLC’s holdings […]
/PRNewswire/ -- In the near future, the AI in pathology industry is poised to revolutionize the field of diagnostics and patient care. Advancements in machine...
Shares of UiPath Inc. (NYSE:PATH – Free Report) were down 2.8% on Thursday . The company traded as low as $16.61 and last traded at $16.68. Approximately 1,524,729 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 7,937,244 shares. The stock had previously closed at $17.16. Wall Street […]
UiPath Inc. (NYSE:PATH – Get Rating) Director Rich Wong sold 43,451 shares of the business’s stock in a transaction that occurred on Tuesday, June 20th. The stock was sold at an average price of $17.98, for a total transaction of $781,248.98. Following the completion of the sale, the director now owns 936,242 shares of the […]
Renaissance Capital LLC lowered its holdings in shares of UiPath Inc. (NYSE:PATH – Get Rating) by 9.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 125,489 shares of the healthcare company’s stock after selling 13,488 shares during the quarter. UiPath comprises about 1.6% […]